General Practice · Ponce, PR
NPI
1730150244
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
606 Ave. Tito Castro, Suite 233 la Rambla Plaza
Ponce, PR, 00716
Phone (787) 840-6838
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$392K
6,860 prescriptions
Company payments, 2025
$66.11
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Edgardo Figueroa-Muniz prescribed most often to Medicare patients was Famotidine, with 330 prescriptions and refills. In total Edgardo Figueroa-Muniz wrote 6,860 Medicare prescriptions that cost $392K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Famotidine Generic | 330 | 522 | 81 | $3,316 |
| Levothyroxine Sodium Generic | 266 | 570 | 65 | $3,886 |
| Synthroid Levothyroxine Sodium | 261 | 427 | 48 | $20K |
| Simvastatin Generic | 256 | 720 | 82 | $2,668 |
| Losartan Potassium Generic | 250 | 702 | 77 | $3,516 |
| Gabapentin Generic | 241 | 393 | 59 | $2,368 |
| Metformin Hcl Generic | 234 | 674 | 74 | $2,159 |
| Atorvastatin Calcium Generic | 232 | 646 | 84 | $3,359 |
| Amlodipine Besylate Generic | 168 | 480 | 65 | $1,175 |
| Rosuvastatin Calcium Generic | 163 | 449 | 53 | $3,141 |
| Tamsulosin Hcl Generic | 148 | 332 | 44 | $2,169 |
| Lisinopril Generic | 146 | 412 | 52 | $1,142 |
| Omeprazole Generic | 139 | 249 | 38 | $1,356 |
| Pantoprazole Sodium Generic | 130 | 236 | 41 | $1,474 |
| Azithromycin Generic | 107 | 107 | 81 | $1,549 |
Brand drugs: 807 claims; generic drugs: 6,024 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edgardo Figueroa-Muniz $66.11 ($66.11 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genzyme Corporation with $43.16.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.